| Literature DB >> 29340887 |
Yao-Long Chen1,2,3,4, Chen Zhao5, Li Zhang6, Bo Li7, Chuan-Hong Wu8, Wei Mu6, Jia-Ying Wang9, Ke-Hu Yang2,3,4, You-Ping Li10, Chiehfeng Chen11, Yong-Yan Wang12, Chen Wang13, Zhao-Xiang Bian5, Hong-Cai Shang14.
Abstract
How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries, various approaches have been used to identify and measure the efficacy and safety of CM. However, the high-quality evidence related to CM that produced in China is still rare. Over the recent years, evidence-based medicine (EBM) has been increasingly applied to CM, strengthening its theoretical basis. This paper reviews the past and present state of CM, analyzes the status quo, challenges and opportunities of basic research, clinical trials, systematic reviews, clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China, pointing out how EBM can help to make CM more widely used and recognized worldwide.Keywords: Chinese medicine; clinical practice guidelines; evidence-based medicine; randomized controlled trial; systematic review
Mesh：
Year: 2018 PMID： 29340887 DOI： 10.1007/s11655-017-2795-2
Source DB: PubMed Journal: Chin J Integr Med ISSN： 1672-0415 Impact factor: 1.978